Show
Sort by
-
The placental growth factor as a target against hepatocellular carcinoma in a diethylnitrosamine induced mouse model
-
Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models
-
Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model
-
Effect of prolyl hydroxylase domain-2 haplodeficiency on the hepatocarcinogenesis in mice
-
Angiogenesis in chronic liver disease and its complications
-
Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice
-
Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease
-
Inhibition of PlGF as a potential therapy against hepatocellular carcinoma
-
- Journal Article
- A1
- open access
Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma